Boston Therapeutics, Inc. (BTHE) Exhibiting PAZ320 at Inaugural Obesity Week 2013 Conference
Boston Therapeutics, a company focusing on the development of drugs using complex carbohydrate chemistry to address diabetes, reported in a news release today it is an exhibitor at the inaugural Obesity Week 2013 Conference in Atlanta, Georgia. The conference, taking place November 13-15, is billed as the world’s largest event on preventing and treating obesity, gathering the world’s leading scientists, clinicians, and surgeons for collaboration, data presentation, and networking. At the conference, Boston Therapeutics will be in Booth #127, presenting information about its PAZ320, a non-systemic chewable tablet drug which targets enzymes that digest sugar during digestion. The drug therefore…